Johnston Press announces Jamie Buchan to its Board as upcoming Non-Executive Director

– UK, Edinburgh – Johnston Press plc (LSE:JPR), one of the leading local media groups in the UK, announces that Jamie Buchan will join the Board as a Non-Executive Director of the Company with effect from 1 June 2017. He replaces Ralph Marshall who will stand down from the Board at the Company’s Annual General Meeting on 22 May 2017. Mr Buchan has been appointed to the Company in accordance with a shareholder agreement between the Company and Gromwell Limited dated 14 May 2008. Gromwell Limited is a member of the same group of companies as Pan Ocean Management Limited, a significant shareholder in the Company. He will become a member of the Company’s Nomination Committee upon appointment.

Jamie is Executive Chairman of Craigewan Limited and a Non-Executive director of Hexadex Group Limited and Tropical Islands Gmbh. He was previously Chief Executive Officer of Southern Cross Healthcare Group plc until his resignation on 15 November 2011. Prior to that he was Chief Executive Officer of London International Exhibition Centre plc having also worked for Whitbread plc and Centrica plc where he held divisional Marketing Director positions. He started his career with Esso plc.

Camilla Rhodes, Interim Chairman of Johnston Press, commented: “On behalf of the Board I am delighted to welcome Jamie Buchan to Johnston Press. His very considerable experience across a number of fields will be of great value to the Company.

“I would like to thank Ralph Marshall for the enormous contribution that he has made to the Board over the past nine years. We wish him well for the future.”

For more information :

- DisclaimerNews, data and statement included in this release are intended exclusively for information purposes. Product and brand names used in this release maybe trademarks or registered trade marks of their respective owners. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of this release. No data or statement in this release should be considered a recommendation for the purchase, retention or sale of the securities referred to herein.

here, the original post =>

Comments are closed.